Apollo

India’s Apollo Hospitals has entered an exclusive collaboration with US-based AliveCor to introduce smartphone-enabled, medical grade and FDA-cleared AliveCor Heart Monitor in India and South Asia to tackle the growing problem of heart arrhythmias.

The product’s launch is part of Apollo Hospitals’ arrhythmia screening and stroke prevention programme providing patients with access to this device.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The new AliveCor Heart Monitor will improve access to cardiac screening tools for patients across India and is compatible with iOS and Android mobile devices to wirelessly record, display, store and transfer heart rate and single-channel electrocardiogram (ECG).

AliveCor president and chief executive officer Euan Thomson said: "We are excited to collaborate with Apollo Hospitals on their mission to improve consumer access to healthcare.

"Together, we can empower patients and their doctors throughout India with a simple, affordable mobile device to help change the way heart conditions are identified and managed."

"It’s extremely important for us to provide access to medical devices that are both clinically proven and cost-effective to help our patients manage their cardiac health."

The new device also displays ECG rhythms and detects the presence of atrial fibrillation

Apollo Hospitals chairman Dr Prathap Reddy said: "We recognise the pioneering work that has been done by AliveCor in the US and also, the great value that this technology can bring to patients as we work to address the problems of arrhythmias in India.

"It’s extremely important for us to provide access to medical devices that are both clinically proven and cost-effective to help our patients manage their cardiac health.

"This agreement is another step in extending the reach of our Apollo health services to members of our community, our cardiac patients and caregivers."

The company said that healthcare professionals, patients with known or suspected heart conditions and health conscious individuals can use the mobile ECG device.

Image: AliveCor Heart Monitor. Photo: courtesy of PRNewsFoto/AliveCor, Inc.